Cargando…
Renal Interstitial Fibrosis and Angiotensin Inhibition
Tubulointerstitial (TI) fibrosis is a final common pathway to progressive renal injury of all forms of renal disease. However, once renal damage reaches a certain threshold, progression of renal disease is consistent, irreversible, and largely independent of the initial injury. Angiotensin (AT) II i...
Autor principal: | Koo, Ja Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Electrolyte and Blood Pressure Research
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894542/ https://www.ncbi.nlm.nih.gov/pubmed/24459483 http://dx.doi.org/10.5049/EBP.2006.4.1.35 |
Ejemplares similares
-
Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis
por: Yan, Yanli, et al.
Publicado: (2016) -
Obstructive nephropathy and molecular pathophysiology of renal interstitial fibrosis
por: Nørregaard, Rikke, et al.
Publicado: (2023) -
Paclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiting STAT3 signaling
por: Zhang, Lei, et al.
Publicado: (2015) -
Proteasome inhibitor MG132 inhibits the process of renal interstitial fibrosis
por: Han, Lin, et al.
Publicado: (2019) -
Fluorofenidone inhibits apoptosis of renal tubular epithelial cells in rats with renal interstitial fibrosis
por: Yang, Hui, et al.
Publicado: (2019)